E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/25/2006 in the Prospect News Biotech Daily.

LCA Vision reiterated at market outperform by JMP

JMP Securities analyst Anthony Ostrea reiterated LCA-Vision Inc. at market outperform and raised its price target to $37, from $36. Third-quarter revenue of $59.3 million, up 26% year-over-year, were relatively in line with JMP's $59.5 million estimate and above consensus estimate of $58.6 million. Shares of the Cincinnati-based laser vision correction services company were up 90 cents, or 2.36%, at $34.76. (Nasdaq: LCAV)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.